nodes	percent_of_prediction	percent_of_DWPC	metapath
Rotigotine—CYP2D6—breast cancer	0.166	0.538	CbGaD
Rotigotine—CYP3A4—breast cancer	0.142	0.462	CbGaD
Rotigotine—CYP1A2—Anastrozole—breast cancer	0.0431	0.109	CbGbCtD
Rotigotine—CYP1A2—Toremifene—breast cancer	0.0394	0.0993	CbGbCtD
Rotigotine—CYP3A4—Exemestane—breast cancer	0.0298	0.0751	CbGbCtD
Rotigotine—CYP2D6—Idarubicin—breast cancer	0.0269	0.0678	CbGbCtD
Rotigotine—CYP3A4—Letrozole—breast cancer	0.0253	0.0638	CbGbCtD
Rotigotine—CYP3A4—Anastrozole—breast cancer	0.0226	0.0569	CbGbCtD
Rotigotine—CYP3A4—Toremifene—breast cancer	0.0206	0.052	CbGbCtD
Rotigotine—CYP3A4—Fulvestrant—breast cancer	0.0192	0.0484	CbGbCtD
Rotigotine—CYP3A4—Thiotepa—breast cancer	0.0171	0.0431	CbGbCtD
Rotigotine—CYP3A4—Ixabepilone—breast cancer	0.0156	0.0394	CbGbCtD
Rotigotine—CYP3A4—Lapatinib—breast cancer	0.0151	0.038	CbGbCtD
Rotigotine—CYP1A2—Tamoxifen—breast cancer	0.0144	0.0363	CbGbCtD
Rotigotine—CYP2D6—Vinorelbine—breast cancer	0.0131	0.0331	CbGbCtD
Rotigotine—CYP2D6—Tamoxifen—breast cancer	0.0119	0.0299	CbGbCtD
Rotigotine—CYP3A4—Raloxifene—breast cancer	0.0114	0.0288	CbGbCtD
Rotigotine—CYP1A2—Fluorouracil—breast cancer	0.0106	0.0267	CbGbCtD
Rotigotine—CYP3A4—Vinorelbine—breast cancer	0.00835	0.0211	CbGbCtD
Rotigotine—CYP2D6—Vinblastine—breast cancer	0.00809	0.0204	CbGbCtD
Rotigotine—CYP3A4—Tamoxifen—breast cancer	0.00754	0.019	CbGbCtD
Rotigotine—CYP3A4—Mitoxantrone—breast cancer	0.00735	0.0185	CbGbCtD
Rotigotine—CYP3A4—Paclitaxel—breast cancer	0.00587	0.0148	CbGbCtD
Rotigotine—CYP3A4—Irinotecan—breast cancer	0.00579	0.0146	CbGbCtD
Rotigotine—CYP3A4—Vinblastine—breast cancer	0.00515	0.013	CbGbCtD
Rotigotine—CYP2D6—Doxorubicin—breast cancer	0.00497	0.0125	CbGbCtD
Rotigotine—CYP3A4—Docetaxel—breast cancer	0.00424	0.0107	CbGbCtD
Rotigotine—CYP3A4—Doxorubicin—breast cancer	0.00316	0.00798	CbGbCtD
Rotigotine—Infection—Docetaxel—breast cancer	6.99e-05	0.000336	CcSEcCtD
Rotigotine—Weight decreased—Doxorubicin—breast cancer	6.98e-05	0.000336	CcSEcCtD
Rotigotine—Sinusitis—Epirubicin—breast cancer	6.98e-05	0.000335	CcSEcCtD
Rotigotine—Diarrhoea—Irinotecan—breast cancer	6.96e-05	0.000335	CcSEcCtD
Rotigotine—Diarrhoea—Mitoxantrone—breast cancer	6.96e-05	0.000335	CcSEcCtD
Rotigotine—Dry mouth—Capecitabine—breast cancer	6.95e-05	0.000334	CcSEcCtD
Rotigotine—Shock—Docetaxel—breast cancer	6.92e-05	0.000333	CcSEcCtD
Rotigotine—Nervous system disorder—Docetaxel—breast cancer	6.9e-05	0.000332	CcSEcCtD
Rotigotine—Pruritus—Fluorouracil—breast cancer	6.9e-05	0.000331	CcSEcCtD
Rotigotine—Infestation NOS—Doxorubicin—breast cancer	6.88e-05	0.000331	CcSEcCtD
Rotigotine—Infestation—Doxorubicin—breast cancer	6.88e-05	0.000331	CcSEcCtD
Rotigotine—Visual impairment—Methotrexate—breast cancer	6.88e-05	0.000331	CcSEcCtD
Rotigotine—Confusional state—Capecitabine—breast cancer	6.87e-05	0.00033	CcSEcCtD
Rotigotine—Feeling abnormal—Paclitaxel—breast cancer	6.84e-05	0.000329	CcSEcCtD
Rotigotine—Skin disorder—Docetaxel—breast cancer	6.83e-05	0.000328	CcSEcCtD
Rotigotine—Diarrhoea—Gemcitabine—breast cancer	6.78e-05	0.000326	CcSEcCtD
Rotigotine—Infection—Capecitabine—breast cancer	6.77e-05	0.000325	CcSEcCtD
Rotigotine—Dizziness—Irinotecan—breast cancer	6.73e-05	0.000323	CcSEcCtD
Rotigotine—Anorexia—Docetaxel—breast cancer	6.71e-05	0.000322	CcSEcCtD
Rotigotine—Shock—Capecitabine—breast cancer	6.7e-05	0.000322	CcSEcCtD
Rotigotine—Nervous system disorder—Capecitabine—breast cancer	6.68e-05	0.000321	CcSEcCtD
Rotigotine—Diarrhoea—Fluorouracil—breast cancer	6.67e-05	0.000321	CcSEcCtD
Rotigotine—Tinnitus—Methotrexate—breast cancer	6.65e-05	0.00032	CcSEcCtD
Rotigotine—Skin disorder—Capecitabine—breast cancer	6.62e-05	0.000318	CcSEcCtD
Rotigotine—Urticaria—Paclitaxel—breast cancer	6.59e-05	0.000317	CcSEcCtD
Rotigotine—Hyperhidrosis—Capecitabine—breast cancer	6.58e-05	0.000316	CcSEcCtD
Rotigotine—Oedema peripheral—Epirubicin—breast cancer	6.58e-05	0.000316	CcSEcCtD
Rotigotine—Hypotension—Docetaxel—breast cancer	6.57e-05	0.000316	CcSEcCtD
Rotigotine—Connective tissue disorder—Epirubicin—breast cancer	6.56e-05	0.000315	CcSEcCtD
Rotigotine—Anorexia—Capecitabine—breast cancer	6.49e-05	0.000312	CcSEcCtD
Rotigotine—Angiopathy—Methotrexate—breast cancer	6.47e-05	0.000311	CcSEcCtD
Rotigotine—Vomiting—Irinotecan—breast cancer	6.47e-05	0.000311	CcSEcCtD
Rotigotine—Vomiting—Mitoxantrone—breast cancer	6.47e-05	0.000311	CcSEcCtD
Rotigotine—Sinusitis—Doxorubicin—breast cancer	6.46e-05	0.00031	CcSEcCtD
Rotigotine—Immune system disorder—Methotrexate—breast cancer	6.45e-05	0.00031	CcSEcCtD
Rotigotine—Dizziness—Fluorouracil—breast cancer	6.45e-05	0.00031	CcSEcCtD
Rotigotine—Visual impairment—Epirubicin—breast cancer	6.44e-05	0.000309	CcSEcCtD
Rotigotine—Mediastinal disorder—Methotrexate—breast cancer	6.43e-05	0.000309	CcSEcCtD
Rotigotine—Rash—Mitoxantrone—breast cancer	6.42e-05	0.000308	CcSEcCtD
Rotigotine—Rash—Irinotecan—breast cancer	6.42e-05	0.000308	CcSEcCtD
Rotigotine—Dermatitis—Irinotecan—breast cancer	6.41e-05	0.000308	CcSEcCtD
Rotigotine—Dermatitis—Mitoxantrone—breast cancer	6.41e-05	0.000308	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Docetaxel—breast cancer	6.41e-05	0.000308	CcSEcCtD
Rotigotine—Headache—Mitoxantrone—breast cancer	6.38e-05	0.000306	CcSEcCtD
Rotigotine—Headache—Irinotecan—breast cancer	6.38e-05	0.000306	CcSEcCtD
Rotigotine—Hypotension—Capecitabine—breast cancer	6.36e-05	0.000306	CcSEcCtD
Rotigotine—Insomnia—Docetaxel—breast cancer	6.36e-05	0.000306	CcSEcCtD
Rotigotine—Paraesthesia—Docetaxel—breast cancer	6.32e-05	0.000304	CcSEcCtD
Rotigotine—Vomiting—Gemcitabine—breast cancer	6.3e-05	0.000303	CcSEcCtD
Rotigotine—Somnolence—Docetaxel—breast cancer	6.25e-05	0.000301	CcSEcCtD
Rotigotine—Mental disorder—Methotrexate—breast cancer	6.25e-05	0.000301	CcSEcCtD
Rotigotine—Rash—Gemcitabine—breast cancer	6.25e-05	0.0003	CcSEcCtD
Rotigotine—Dermatitis—Gemcitabine—breast cancer	6.24e-05	0.0003	CcSEcCtD
Rotigotine—Tinnitus—Epirubicin—breast cancer	6.23e-05	0.000299	CcSEcCtD
Rotigotine—Erythema—Methotrexate—breast cancer	6.21e-05	0.000299	CcSEcCtD
Rotigotine—Malnutrition—Methotrexate—breast cancer	6.21e-05	0.000299	CcSEcCtD
Rotigotine—Headache—Gemcitabine—breast cancer	6.21e-05	0.000298	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Capecitabine—breast cancer	6.21e-05	0.000298	CcSEcCtD
Rotigotine—Vomiting—Fluorouracil—breast cancer	6.2e-05	0.000298	CcSEcCtD
Rotigotine—Dyspepsia—Docetaxel—breast cancer	6.19e-05	0.000298	CcSEcCtD
Rotigotine—Insomnia—Capecitabine—breast cancer	6.16e-05	0.000296	CcSEcCtD
Rotigotine—Rash—Fluorouracil—breast cancer	6.15e-05	0.000295	CcSEcCtD
Rotigotine—Dermatitis—Fluorouracil—breast cancer	6.14e-05	0.000295	CcSEcCtD
Rotigotine—Paraesthesia—Capecitabine—breast cancer	6.12e-05	0.000294	CcSEcCtD
Rotigotine—Decreased appetite—Docetaxel—breast cancer	6.12e-05	0.000294	CcSEcCtD
Rotigotine—Hypersensitivity—Paclitaxel—breast cancer	6.11e-05	0.000294	CcSEcCtD
Rotigotine—Headache—Fluorouracil—breast cancer	6.11e-05	0.000293	CcSEcCtD
Rotigotine—Oedema peripheral—Doxorubicin—breast cancer	6.09e-05	0.000293	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Docetaxel—breast cancer	6.07e-05	0.000292	CcSEcCtD
Rotigotine—Connective tissue disorder—Doxorubicin—breast cancer	6.07e-05	0.000292	CcSEcCtD
Rotigotine—Fatigue—Docetaxel—breast cancer	6.07e-05	0.000292	CcSEcCtD
Rotigotine—Angiopathy—Epirubicin—breast cancer	6.06e-05	0.000291	CcSEcCtD
Rotigotine—Nausea—Mitoxantrone—breast cancer	6.04e-05	0.000291	CcSEcCtD
Rotigotine—Nausea—Irinotecan—breast cancer	6.04e-05	0.000291	CcSEcCtD
Rotigotine—Immune system disorder—Epirubicin—breast cancer	6.03e-05	0.00029	CcSEcCtD
Rotigotine—Mediastinal disorder—Epirubicin—breast cancer	6.02e-05	0.000289	CcSEcCtD
Rotigotine—Pain—Docetaxel—breast cancer	6.02e-05	0.000289	CcSEcCtD
Rotigotine—Constipation—Docetaxel—breast cancer	6.02e-05	0.000289	CcSEcCtD
Rotigotine—Dyspepsia—Capecitabine—breast cancer	6e-05	0.000288	CcSEcCtD
Rotigotine—Visual impairment—Doxorubicin—breast cancer	5.96e-05	0.000286	CcSEcCtD
Rotigotine—Asthenia—Paclitaxel—breast cancer	5.95e-05	0.000286	CcSEcCtD
Rotigotine—Decreased appetite—Capecitabine—breast cancer	5.92e-05	0.000285	CcSEcCtD
Rotigotine—Nausea—Gemcitabine—breast cancer	5.89e-05	0.000283	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Capecitabine—breast cancer	5.88e-05	0.000283	CcSEcCtD
Rotigotine—Fatigue—Capecitabine—breast cancer	5.87e-05	0.000282	CcSEcCtD
Rotigotine—Pruritus—Paclitaxel—breast cancer	5.87e-05	0.000282	CcSEcCtD
Rotigotine—Mental disorder—Epirubicin—breast cancer	5.85e-05	0.000281	CcSEcCtD
Rotigotine—Pain—Capecitabine—breast cancer	5.82e-05	0.00028	CcSEcCtD
Rotigotine—Constipation—Capecitabine—breast cancer	5.82e-05	0.00028	CcSEcCtD
Rotigotine—Malnutrition—Epirubicin—breast cancer	5.81e-05	0.000279	CcSEcCtD
Rotigotine—Erythema—Epirubicin—breast cancer	5.81e-05	0.000279	CcSEcCtD
Rotigotine—Feeling abnormal—Docetaxel—breast cancer	5.8e-05	0.000279	CcSEcCtD
Rotigotine—Nausea—Fluorouracil—breast cancer	5.79e-05	0.000278	CcSEcCtD
Rotigotine—Ill-defined disorder—Methotrexate—breast cancer	5.76e-05	0.000277	CcSEcCtD
Rotigotine—Tinnitus—Doxorubicin—breast cancer	5.76e-05	0.000277	CcSEcCtD
Rotigotine—Diarrhoea—Paclitaxel—breast cancer	5.68e-05	0.000273	CcSEcCtD
Rotigotine—Feeling abnormal—Capecitabine—breast cancer	5.61e-05	0.00027	CcSEcCtD
Rotigotine—Angiopathy—Doxorubicin—breast cancer	5.61e-05	0.000269	CcSEcCtD
Rotigotine—Malaise—Methotrexate—breast cancer	5.6e-05	0.000269	CcSEcCtD
Rotigotine—Muscle spasms—Epirubicin—breast cancer	5.59e-05	0.000269	CcSEcCtD
Rotigotine—Immune system disorder—Doxorubicin—breast cancer	5.58e-05	0.000268	CcSEcCtD
Rotigotine—Vertigo—Methotrexate—breast cancer	5.58e-05	0.000268	CcSEcCtD
Rotigotine—Mediastinal disorder—Doxorubicin—breast cancer	5.57e-05	0.000268	CcSEcCtD
Rotigotine—Dizziness—Paclitaxel—breast cancer	5.49e-05	0.000264	CcSEcCtD
Rotigotine—Cough—Methotrexate—breast cancer	5.42e-05	0.000261	CcSEcCtD
Rotigotine—Mental disorder—Doxorubicin—breast cancer	5.41e-05	0.00026	CcSEcCtD
Rotigotine—Urticaria—Capecitabine—breast cancer	5.41e-05	0.00026	CcSEcCtD
Rotigotine—Ill-defined disorder—Epirubicin—breast cancer	5.39e-05	0.000259	CcSEcCtD
Rotigotine—Malnutrition—Doxorubicin—breast cancer	5.38e-05	0.000259	CcSEcCtD
Rotigotine—Erythema—Doxorubicin—breast cancer	5.38e-05	0.000259	CcSEcCtD
Rotigotine—Agitation—Epirubicin—breast cancer	5.34e-05	0.000257	CcSEcCtD
Rotigotine—Arthralgia—Methotrexate—breast cancer	5.29e-05	0.000254	CcSEcCtD
Rotigotine—Vomiting—Paclitaxel—breast cancer	5.28e-05	0.000254	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	5.25e-05	0.000252	CcSEcCtD
Rotigotine—Malaise—Epirubicin—breast cancer	5.24e-05	0.000252	CcSEcCtD
Rotigotine—Rash—Paclitaxel—breast cancer	5.23e-05	0.000252	CcSEcCtD
Rotigotine—Dermatitis—Paclitaxel—breast cancer	5.23e-05	0.000251	CcSEcCtD
Rotigotine—Discomfort—Methotrexate—breast cancer	5.23e-05	0.000251	CcSEcCtD
Rotigotine—Vertigo—Epirubicin—breast cancer	5.22e-05	0.000251	CcSEcCtD
Rotigotine—Syncope—Epirubicin—breast cancer	5.21e-05	0.000251	CcSEcCtD
Rotigotine—Headache—Paclitaxel—breast cancer	5.2e-05	0.00025	CcSEcCtD
Rotigotine—Hypersensitivity—Docetaxel—breast cancer	5.18e-05	0.000249	CcSEcCtD
Rotigotine—Muscle spasms—Doxorubicin—breast cancer	5.17e-05	0.000249	CcSEcCtD
Rotigotine—Confusional state—Methotrexate—breast cancer	5.11e-05	0.000246	CcSEcCtD
Rotigotine—Loss of consciousness—Epirubicin—breast cancer	5.11e-05	0.000246	CcSEcCtD
Rotigotine—Cough—Epirubicin—breast cancer	5.07e-05	0.000244	CcSEcCtD
Rotigotine—Asthenia—Docetaxel—breast cancer	5.05e-05	0.000243	CcSEcCtD
Rotigotine—Infection—Methotrexate—breast cancer	5.04e-05	0.000242	CcSEcCtD
Rotigotine—Hypertension—Epirubicin—breast cancer	5.02e-05	0.000241	CcSEcCtD
Rotigotine—Hypersensitivity—Capecitabine—breast cancer	5.02e-05	0.000241	CcSEcCtD
Rotigotine—Ill-defined disorder—Doxorubicin—breast cancer	4.99e-05	0.00024	CcSEcCtD
Rotigotine—Pruritus—Docetaxel—breast cancer	4.98e-05	0.000239	CcSEcCtD
Rotigotine—Nervous system disorder—Methotrexate—breast cancer	4.97e-05	0.000239	CcSEcCtD
Rotigotine—Arthralgia—Epirubicin—breast cancer	4.95e-05	0.000238	CcSEcCtD
Rotigotine—Agitation—Doxorubicin—breast cancer	4.94e-05	0.000238	CcSEcCtD
Rotigotine—Nausea—Paclitaxel—breast cancer	4.93e-05	0.000237	CcSEcCtD
Rotigotine—Skin disorder—Methotrexate—breast cancer	4.92e-05	0.000237	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	4.92e-05	0.000236	CcSEcCtD
Rotigotine—Hyperhidrosis—Methotrexate—breast cancer	4.9e-05	0.000236	CcSEcCtD
Rotigotine—Discomfort—Epirubicin—breast cancer	4.89e-05	0.000235	CcSEcCtD
Rotigotine—Asthenia—Capecitabine—breast cancer	4.89e-05	0.000235	CcSEcCtD
Rotigotine—Malaise—Doxorubicin—breast cancer	4.85e-05	0.000233	CcSEcCtD
Rotigotine—Dry mouth—Epirubicin—breast cancer	4.84e-05	0.000233	CcSEcCtD
Rotigotine—Vertigo—Doxorubicin—breast cancer	4.83e-05	0.000232	CcSEcCtD
Rotigotine—Anorexia—Methotrexate—breast cancer	4.83e-05	0.000232	CcSEcCtD
Rotigotine—Syncope—Doxorubicin—breast cancer	4.82e-05	0.000232	CcSEcCtD
Rotigotine—Pruritus—Capecitabine—breast cancer	4.82e-05	0.000232	CcSEcCtD
Rotigotine—Diarrhoea—Docetaxel—breast cancer	4.81e-05	0.000231	CcSEcCtD
Rotigotine—Confusional state—Epirubicin—breast cancer	4.78e-05	0.00023	CcSEcCtD
Rotigotine—Hypotension—Methotrexate—breast cancer	4.74e-05	0.000228	CcSEcCtD
Rotigotine—Loss of consciousness—Doxorubicin—breast cancer	4.73e-05	0.000227	CcSEcCtD
Rotigotine—Infection—Epirubicin—breast cancer	4.71e-05	0.000227	CcSEcCtD
Rotigotine—Cough—Doxorubicin—breast cancer	4.69e-05	0.000226	CcSEcCtD
Rotigotine—Shock—Epirubicin—breast cancer	4.67e-05	0.000224	CcSEcCtD
Rotigotine—Diarrhoea—Capecitabine—breast cancer	4.66e-05	0.000224	CcSEcCtD
Rotigotine—Nervous system disorder—Epirubicin—breast cancer	4.65e-05	0.000224	CcSEcCtD
Rotigotine—Dizziness—Docetaxel—breast cancer	4.65e-05	0.000224	CcSEcCtD
Rotigotine—Hypertension—Doxorubicin—breast cancer	4.64e-05	0.000223	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Methotrexate—breast cancer	4.62e-05	0.000222	CcSEcCtD
Rotigotine—Skin disorder—Epirubicin—breast cancer	4.61e-05	0.000222	CcSEcCtD
Rotigotine—Hyperhidrosis—Epirubicin—breast cancer	4.59e-05	0.00022	CcSEcCtD
Rotigotine—Insomnia—Methotrexate—breast cancer	4.59e-05	0.00022	CcSEcCtD
Rotigotine—Arthralgia—Doxorubicin—breast cancer	4.58e-05	0.00022	CcSEcCtD
Rotigotine—Paraesthesia—Methotrexate—breast cancer	4.55e-05	0.000219	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	4.55e-05	0.000219	CcSEcCtD
Rotigotine—Discomfort—Doxorubicin—breast cancer	4.52e-05	0.000217	CcSEcCtD
Rotigotine—Anorexia—Epirubicin—breast cancer	4.52e-05	0.000217	CcSEcCtD
Rotigotine—Somnolence—Methotrexate—breast cancer	4.51e-05	0.000217	CcSEcCtD
Rotigotine—Dizziness—Capecitabine—breast cancer	4.5e-05	0.000216	CcSEcCtD
Rotigotine—Dry mouth—Doxorubicin—breast cancer	4.48e-05	0.000215	CcSEcCtD
Rotigotine—Vomiting—Docetaxel—breast cancer	4.47e-05	0.000215	CcSEcCtD
Rotigotine—Dyspepsia—Methotrexate—breast cancer	4.46e-05	0.000215	CcSEcCtD
Rotigotine—Rash—Docetaxel—breast cancer	4.44e-05	0.000213	CcSEcCtD
Rotigotine—Hypotension—Epirubicin—breast cancer	4.43e-05	0.000213	CcSEcCtD
Rotigotine—Dermatitis—Docetaxel—breast cancer	4.43e-05	0.000213	CcSEcCtD
Rotigotine—Confusional state—Doxorubicin—breast cancer	4.43e-05	0.000213	CcSEcCtD
Rotigotine—Decreased appetite—Methotrexate—breast cancer	4.41e-05	0.000212	CcSEcCtD
Rotigotine—Headache—Docetaxel—breast cancer	4.41e-05	0.000212	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Methotrexate—breast cancer	4.38e-05	0.00021	CcSEcCtD
Rotigotine—Fatigue—Methotrexate—breast cancer	4.37e-05	0.00021	CcSEcCtD
Rotigotine—Infection—Doxorubicin—breast cancer	4.36e-05	0.00021	CcSEcCtD
Rotigotine—Pain—Methotrexate—breast cancer	4.34e-05	0.000208	CcSEcCtD
Rotigotine—Vomiting—Capecitabine—breast cancer	4.33e-05	0.000208	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Epirubicin—breast cancer	4.32e-05	0.000208	CcSEcCtD
Rotigotine—Shock—Doxorubicin—breast cancer	4.32e-05	0.000208	CcSEcCtD
Rotigotine—Nervous system disorder—Doxorubicin—breast cancer	4.31e-05	0.000207	CcSEcCtD
Rotigotine—Rash—Capecitabine—breast cancer	4.29e-05	0.000206	CcSEcCtD
Rotigotine—Insomnia—Epirubicin—breast cancer	4.29e-05	0.000206	CcSEcCtD
Rotigotine—Dermatitis—Capecitabine—breast cancer	4.29e-05	0.000206	CcSEcCtD
Rotigotine—Headache—Capecitabine—breast cancer	4.27e-05	0.000205	CcSEcCtD
Rotigotine—Skin disorder—Doxorubicin—breast cancer	4.26e-05	0.000205	CcSEcCtD
Rotigotine—Paraesthesia—Epirubicin—breast cancer	4.26e-05	0.000205	CcSEcCtD
Rotigotine—Hyperhidrosis—Doxorubicin—breast cancer	4.24e-05	0.000204	CcSEcCtD
Rotigotine—Somnolence—Epirubicin—breast cancer	4.22e-05	0.000203	CcSEcCtD
Rotigotine—Anorexia—Doxorubicin—breast cancer	4.18e-05	0.000201	CcSEcCtD
Rotigotine—Nausea—Docetaxel—breast cancer	4.18e-05	0.000201	CcSEcCtD
Rotigotine—Feeling abnormal—Methotrexate—breast cancer	4.18e-05	0.000201	CcSEcCtD
Rotigotine—Dyspepsia—Epirubicin—breast cancer	4.18e-05	0.000201	CcSEcCtD
Rotigotine—Decreased appetite—Epirubicin—breast cancer	4.12e-05	0.000198	CcSEcCtD
Rotigotine—Hypotension—Doxorubicin—breast cancer	4.1e-05	0.000197	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Epirubicin—breast cancer	4.1e-05	0.000197	CcSEcCtD
Rotigotine—Fatigue—Epirubicin—breast cancer	4.09e-05	0.000197	CcSEcCtD
Rotigotine—Pain—Epirubicin—breast cancer	4.06e-05	0.000195	CcSEcCtD
Rotigotine—Constipation—Epirubicin—breast cancer	4.06e-05	0.000195	CcSEcCtD
Rotigotine—Nausea—Capecitabine—breast cancer	4.05e-05	0.000194	CcSEcCtD
Rotigotine—Urticaria—Methotrexate—breast cancer	4.03e-05	0.000194	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Doxorubicin—breast cancer	4e-05	0.000192	CcSEcCtD
Rotigotine—Insomnia—Doxorubicin—breast cancer	3.97e-05	0.000191	CcSEcCtD
Rotigotine—Paraesthesia—Doxorubicin—breast cancer	3.94e-05	0.000189	CcSEcCtD
Rotigotine—Feeling abnormal—Epirubicin—breast cancer	3.91e-05	0.000188	CcSEcCtD
Rotigotine—Somnolence—Doxorubicin—breast cancer	3.9e-05	0.000188	CcSEcCtD
Rotigotine—Dyspepsia—Doxorubicin—breast cancer	3.86e-05	0.000186	CcSEcCtD
Rotigotine—Decreased appetite—Doxorubicin—breast cancer	3.82e-05	0.000183	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Doxorubicin—breast cancer	3.79e-05	0.000182	CcSEcCtD
Rotigotine—Fatigue—Doxorubicin—breast cancer	3.79e-05	0.000182	CcSEcCtD
Rotigotine—Urticaria—Epirubicin—breast cancer	3.77e-05	0.000181	CcSEcCtD
Rotigotine—Pain—Doxorubicin—breast cancer	3.75e-05	0.00018	CcSEcCtD
Rotigotine—Constipation—Doxorubicin—breast cancer	3.75e-05	0.00018	CcSEcCtD
Rotigotine—Hypersensitivity—Methotrexate—breast cancer	3.74e-05	0.00018	CcSEcCtD
Rotigotine—Asthenia—Methotrexate—breast cancer	3.64e-05	0.000175	CcSEcCtD
Rotigotine—Feeling abnormal—Doxorubicin—breast cancer	3.62e-05	0.000174	CcSEcCtD
Rotigotine—Pruritus—Methotrexate—breast cancer	3.59e-05	0.000172	CcSEcCtD
Rotigotine—Hypersensitivity—Epirubicin—breast cancer	3.5e-05	0.000168	CcSEcCtD
Rotigotine—Urticaria—Doxorubicin—breast cancer	3.49e-05	0.000168	CcSEcCtD
Rotigotine—Diarrhoea—Methotrexate—breast cancer	3.47e-05	0.000167	CcSEcCtD
Rotigotine—Asthenia—Epirubicin—breast cancer	3.4e-05	0.000164	CcSEcCtD
Rotigotine—Pruritus—Epirubicin—breast cancer	3.36e-05	0.000161	CcSEcCtD
Rotigotine—Dizziness—Methotrexate—breast cancer	3.35e-05	0.000161	CcSEcCtD
Rotigotine—Diarrhoea—Epirubicin—breast cancer	3.25e-05	0.000156	CcSEcCtD
Rotigotine—Hypersensitivity—Doxorubicin—breast cancer	3.23e-05	0.000155	CcSEcCtD
Rotigotine—Vomiting—Methotrexate—breast cancer	3.22e-05	0.000155	CcSEcCtD
Rotigotine—Rash—Methotrexate—breast cancer	3.2e-05	0.000154	CcSEcCtD
Rotigotine—Dermatitis—Methotrexate—breast cancer	3.19e-05	0.000154	CcSEcCtD
Rotigotine—Headache—Methotrexate—breast cancer	3.18e-05	0.000153	CcSEcCtD
Rotigotine—Asthenia—Doxorubicin—breast cancer	3.15e-05	0.000151	CcSEcCtD
Rotigotine—Dizziness—Epirubicin—breast cancer	3.14e-05	0.000151	CcSEcCtD
Rotigotine—Pruritus—Doxorubicin—breast cancer	3.11e-05	0.000149	CcSEcCtD
Rotigotine—Vomiting—Epirubicin—breast cancer	3.02e-05	0.000145	CcSEcCtD
Rotigotine—Nausea—Methotrexate—breast cancer	3.01e-05	0.000145	CcSEcCtD
Rotigotine—Diarrhoea—Doxorubicin—breast cancer	3e-05	0.000144	CcSEcCtD
Rotigotine—Rash—Epirubicin—breast cancer	2.99e-05	0.000144	CcSEcCtD
Rotigotine—Dermatitis—Epirubicin—breast cancer	2.99e-05	0.000144	CcSEcCtD
Rotigotine—Headache—Epirubicin—breast cancer	2.97e-05	0.000143	CcSEcCtD
Rotigotine—Dizziness—Doxorubicin—breast cancer	2.9e-05	0.00014	CcSEcCtD
Rotigotine—Nausea—Epirubicin—breast cancer	2.82e-05	0.000135	CcSEcCtD
Rotigotine—Vomiting—Doxorubicin—breast cancer	2.79e-05	0.000134	CcSEcCtD
Rotigotine—Rash—Doxorubicin—breast cancer	2.77e-05	0.000133	CcSEcCtD
Rotigotine—Dermatitis—Doxorubicin—breast cancer	2.77e-05	0.000133	CcSEcCtD
Rotigotine—Headache—Doxorubicin—breast cancer	2.75e-05	0.000132	CcSEcCtD
Rotigotine—Nausea—Doxorubicin—breast cancer	2.61e-05	0.000125	CcSEcCtD
Rotigotine—ADRA2B—Signaling Pathways—RAF1—breast cancer	3.8e-06	4.35e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—RELA—breast cancer	3.79e-06	4.33e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CASP3—breast cancer	3.78e-06	4.33e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—IL2—breast cancer	3.78e-06	4.32e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—ERBB2—breast cancer	3.76e-06	4.3e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—IGF1—breast cancer	3.76e-06	4.3e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—IL6—breast cancer	3.76e-06	4.3e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—AKT2—breast cancer	3.76e-06	4.3e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CYP17A1—breast cancer	3.75e-06	4.29e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—EGFR—breast cancer	3.74e-06	4.28e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CCND1—breast cancer	3.73e-06	4.27e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—JUN—breast cancer	3.72e-06	4.26e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MTOR—breast cancer	3.71e-06	4.25e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—PIK3CB—breast cancer	3.71e-06	4.25e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ENO1—breast cancer	3.71e-06	4.24e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PTGS1—breast cancer	3.71e-06	4.24e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—SRC—breast cancer	3.71e-06	4.24e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—TP53—breast cancer	3.7e-06	4.23e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—PIK3CA—breast cancer	3.7e-06	4.23e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CTNNB1—breast cancer	3.69e-06	4.23e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—GPX1—breast cancer	3.69e-06	4.23e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MDM2—breast cancer	3.68e-06	4.21e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CCND1—breast cancer	3.68e-06	4.21e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—JUN—breast cancer	3.67e-06	4.2e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—RAF1—breast cancer	3.67e-06	4.2e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—CYP1A1—breast cancer	3.66e-06	4.18e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—RELA—breast cancer	3.65e-06	4.18e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CTNNB1—breast cancer	3.65e-06	4.17e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CYP2D6—breast cancer	3.64e-06	4.16e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—ERBB2—breast cancer	3.63e-06	4.15e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—ERCC2—breast cancer	3.63e-06	4.15e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—MMP9—breast cancer	3.62e-06	4.14e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—VEGFA—breast cancer	3.61e-06	4.13e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PIK3CD—breast cancer	3.61e-06	4.13e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CDKN1A—breast cancer	3.61e-06	4.13e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.61e-06	4.13e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—PTEN—breast cancer	3.6e-06	4.12e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MTOR—breast cancer	3.58e-06	4.1e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PIK3CB—breast cancer	3.58e-06	4.1e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—STAT3—breast cancer	3.58e-06	4.09e-05	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—PIK3CA—breast cancer	3.58e-06	4.09e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MMP9—breast cancer	3.57e-06	4.09e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—COMT—breast cancer	3.57e-06	4.09e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—NCOA2—breast cancer	3.57e-06	4.08e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—SERPINE1—breast cancer	3.57e-06	4.08e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CXCL8—breast cancer	3.57e-06	4.08e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CDKN1A—breast cancer	3.56e-06	4.07e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GSTP1—breast cancer	3.56e-06	4.07e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—PTEN—breast cancer	3.55e-06	4.06e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—HRAS—breast cancer	3.54e-06	4.05e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—HRAS—breast cancer	3.54e-06	4.05e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—KRAS—breast cancer	3.53e-06	4.04e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—MAPK8—breast cancer	3.52e-06	4.03e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—AKT1—breast cancer	3.51e-06	4.02e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—HMOX1—breast cancer	3.51e-06	4.01e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—ITPR1—breast cancer	3.5e-06	4e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CDKN1B—breast cancer	3.48e-06	3.98e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MAPK8—breast cancer	3.48e-06	3.98e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—AKT1—breast cancer	3.47e-06	3.96e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—FASN—breast cancer	3.46e-06	3.96e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—BCHE—breast cancer	3.45e-06	3.95e-05	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—AKT1—breast cancer	3.45e-06	3.94e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CXCL8—breast cancer	3.44e-06	3.94e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—HRAS—breast cancer	3.42e-06	3.91e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—MAPK3—breast cancer	3.42e-06	3.91e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CASP3—breast cancer	3.41e-06	3.9e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—MTHFR—breast cancer	3.41e-06	3.9e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—IL2—breast cancer	3.41e-06	3.9e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—NOS3—breast cancer	3.41e-06	3.9e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—SLC5A5—breast cancer	3.41e-06	3.9e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—IL6—breast cancer	3.39e-06	3.88e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—IL6—breast cancer	3.39e-06	3.87e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—ABCB1—breast cancer	3.37e-06	3.85e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CDKN1B—breast cancer	3.36e-06	3.85e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—SRC—breast cancer	3.34e-06	3.82e-05	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—AKT1—breast cancer	3.33e-06	3.8e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—MYC—breast cancer	3.32e-06	3.8e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CCND1—breast cancer	3.32e-06	3.8e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—JUN—breast cancer	3.32e-06	3.79e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—TGFB1—breast cancer	3.32e-06	3.79e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—TYMS—breast cancer	3.31e-06	3.78e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CASP3—breast cancer	3.3e-06	3.77e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—SRC—breast cancer	3.29e-06	3.77e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CTNNB1—breast cancer	3.29e-06	3.76e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—IL2—breast cancer	3.29e-06	3.76e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—NQO1—breast cancer	3.29e-06	3.76e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—SLC2A1—breast cancer	3.29e-06	3.76e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—IL6—breast cancer	3.27e-06	3.75e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—NCOR1—breast cancer	3.27e-06	3.74e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PLA2G4A—breast cancer	3.27e-06	3.74e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GSTM1—breast cancer	3.27e-06	3.74e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—VEGFA—breast cancer	3.25e-06	3.72e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—EGFR—breast cancer	3.25e-06	3.72e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—PIK3CA—breast cancer	3.25e-06	3.71e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MDM2—breast cancer	3.23e-06	3.7e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MMP9—breast cancer	3.23e-06	3.69e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—RAF1—breast cancer	3.22e-06	3.69e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—STAT3—breast cancer	3.22e-06	3.68e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CDKN1A—breast cancer	3.21e-06	3.68e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—VEGFA—breast cancer	3.21e-06	3.67e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—RELA—breast cancer	3.21e-06	3.67e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CCND1—breast cancer	3.21e-06	3.67e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—PTEN—breast cancer	3.21e-06	3.67e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—JUN—breast cancer	3.2e-06	3.66e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—ERBB2—breast cancer	3.19e-06	3.65e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—STAT3—breast cancer	3.18e-06	3.63e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CTNNB1—breast cancer	3.18e-06	3.63e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CYP1B1—breast cancer	3.15e-06	3.61e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PIK3CB—breast cancer	3.15e-06	3.6e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MTOR—breast cancer	3.15e-06	3.6e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—CAV1—breast cancer	3.14e-06	3.6e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MAPK8—breast cancer	3.14e-06	3.59e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GPX1—breast cancer	3.13e-06	3.58e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—AKT1—breast cancer	3.13e-06	3.58e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—AKT1—breast cancer	3.12e-06	3.57e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MMP9—breast cancer	3.11e-06	3.56e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CDKN1A—breast cancer	3.1e-06	3.55e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CYP1A1—breast cancer	3.1e-06	3.54e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PTEN—breast cancer	3.1e-06	3.54e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—HSP90AA1—breast cancer	3.09e-06	3.54e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—MAPK3—breast cancer	3.08e-06	3.52e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—ERCC2—breast cancer	3.07e-06	3.51e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—KRAS—breast cancer	3.07e-06	3.51e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MAPK3—breast cancer	3.04e-06	3.47e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MAPK8—breast cancer	3.03e-06	3.46e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CXCL8—breast cancer	3.02e-06	3.46e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—AKT1—breast cancer	3.02e-06	3.46e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—NCOA1—breast cancer	3.01e-06	3.44e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—HRAS—breast cancer	3e-06	3.44e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—MYC—breast cancer	2.99e-06	3.42e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—TGFB1—breast cancer	2.98e-06	3.41e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—SRC—breast cancer	2.97e-06	3.4e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—STK11—breast cancer	2.97e-06	3.39e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CYP19A1—breast cancer	2.97e-06	3.39e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MYC—breast cancer	2.95e-06	3.38e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CDKN1B—breast cancer	2.95e-06	3.38e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—TGFB1—breast cancer	2.95e-06	3.37e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—EGFR—breast cancer	2.93e-06	3.35e-05	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—AKT1—breast cancer	2.92e-06	3.34e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—VEGFA—breast cancer	2.9e-06	3.31e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CASP3—breast cancer	2.89e-06	3.31e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—IL2—breast cancer	2.89e-06	3.3e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—MTHFR—breast cancer	2.89e-06	3.3e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—EGFR—breast cancer	2.89e-06	3.3e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—IL6—breast cancer	2.87e-06	3.29e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—SRC—breast cancer	2.87e-06	3.28e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—STAT3—breast cancer	2.87e-06	3.28e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PIK3CG—breast cancer	2.86e-06	3.28e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—PIK3CA—breast cancer	2.82e-06	3.23e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CCND1—breast cancer	2.82e-06	3.22e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—JUN—breast cancer	2.81e-06	3.21e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—VEGFA—breast cancer	2.8e-06	3.2e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CTNNB1—breast cancer	2.79e-06	3.19e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—STAT3—breast cancer	2.77e-06	3.17e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—KRAS—breast cancer	2.76e-06	3.16e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—COMT—breast cancer	2.76e-06	3.15e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GSTP1—breast cancer	2.74e-06	3.14e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MAPK3—breast cancer	2.74e-06	3.13e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MMP9—breast cancer	2.73e-06	3.13e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—TP53—breast cancer	2.73e-06	3.12e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—KRAS—breast cancer	2.73e-06	3.12e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CDKN1A—breast cancer	2.72e-06	3.12e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PTEN—breast cancer	2.72e-06	3.11e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—HMOX1—breast cancer	2.71e-06	3.1e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ITPR1—breast cancer	2.7e-06	3.09e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MYC—breast cancer	2.67e-06	3.05e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CAV1—breast cancer	2.66e-06	3.05e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MAPK8—breast cancer	2.66e-06	3.04e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—TGFB1—breast cancer	2.66e-06	3.04e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—AKT1—breast cancer	2.65e-06	3.03e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MAPK3—breast cancer	2.65e-06	3.03e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—HRAS—breast cancer	2.61e-06	2.99e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—EGFR—breast cancer	2.61e-06	2.98e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ABCB1—breast cancer	2.6e-06	2.97e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MYC—breast cancer	2.57e-06	2.94e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—TGFB1—breast cancer	2.57e-06	2.94e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—TYMS—breast cancer	2.55e-06	2.92e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.54e-06	2.91e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—PIK3CA—breast cancer	2.54e-06	2.91e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GSTM1—breast cancer	2.52e-06	2.88e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.52e-06	2.88e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—NCOR1—breast cancer	2.52e-06	2.88e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—SRC—breast cancer	2.52e-06	2.88e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PIK3CD—breast cancer	2.52e-06	2.88e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—EGFR—breast cancer	2.52e-06	2.88e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—PIK3CA—breast cancer	2.51e-06	2.87e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—IL6—breast cancer	2.5e-06	2.86e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—ALB—breast cancer	2.49e-06	2.84e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—KRAS—breast cancer	2.46e-06	2.82e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—TP53—breast cancer	2.46e-06	2.81e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—VEGFA—breast cancer	2.46e-06	2.81e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—STAT3—breast cancer	2.43e-06	2.78e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PIK3CG—breast cancer	2.43e-06	2.78e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—TP53—breast cancer	2.42e-06	2.77e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GPX1—breast cancer	2.42e-06	2.76e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CYP1A1—breast cancer	2.39e-06	2.73e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—NOS3—breast cancer	2.38e-06	2.72e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—KRAS—breast cancer	2.38e-06	2.72e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ERCC2—breast cancer	2.37e-06	2.71e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—HRAS—breast cancer	2.35e-06	2.69e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MAPK3—breast cancer	2.32e-06	2.66e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—HRAS—breast cancer	2.32e-06	2.65e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—AKT1—breast cancer	2.31e-06	2.64e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—PIK3CA—breast cancer	2.26e-06	2.59e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MYC—breast cancer	2.26e-06	2.58e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—TGFB1—breast cancer	2.25e-06	2.58e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—IL6—breast cancer	2.25e-06	2.57e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—MTHFR—breast cancer	2.23e-06	2.55e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—IL6—breast cancer	2.22e-06	2.54e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—EGFR—breast cancer	2.21e-06	2.53e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PIK3CB—breast cancer	2.19e-06	2.51e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—TP53—breast cancer	2.19e-06	2.5e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PIK3CA—breast cancer	2.18e-06	2.5e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PTGS2—breast cancer	2.17e-06	2.49e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PIK3CD—breast cancer	2.13e-06	2.44e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—TP53—breast cancer	2.11e-06	2.42e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—ALB—breast cancer	2.11e-06	2.41e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—HRAS—breast cancer	2.09e-06	2.39e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—KRAS—breast cancer	2.09e-06	2.39e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—AKT1—breast cancer	2.08e-06	2.37e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CAV1—breast cancer	2.06e-06	2.35e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—AKT1—breast cancer	2.05e-06	2.34e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—HRAS—breast cancer	2.02e-06	2.31e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—NOS3—breast cancer	2.01e-06	2.3e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—IL6—breast cancer	2e-06	2.29e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—IL6—breast cancer	1.93e-06	2.21e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PIK3CA—breast cancer	1.92e-06	2.19e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PTEN—breast cancer	1.9e-06	2.17e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PIK3CG—breast cancer	1.87e-06	2.14e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PIK3CB—breast cancer	1.86e-06	2.13e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—TP53—breast cancer	1.86e-06	2.12e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—AKT1—breast cancer	1.85e-06	2.11e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PTGS2—breast cancer	1.84e-06	2.11e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—AKT1—breast cancer	1.78e-06	2.04e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—HRAS—breast cancer	1.77e-06	2.03e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—IL6—breast cancer	1.7e-06	1.94e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PIK3CD—breast cancer	1.65e-06	1.88e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ALB—breast cancer	1.63e-06	1.86e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PTEN—breast cancer	1.61e-06	1.84e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—AKT1—breast cancer	1.57e-06	1.79e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—NOS3—breast cancer	1.55e-06	1.78e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PIK3CB—breast cancer	1.43e-06	1.64e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PTGS2—breast cancer	1.42e-06	1.63e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PIK3CA—breast cancer	1.34e-06	1.53e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PTEN—breast cancer	1.24e-06	1.42e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PIK3CA—breast cancer	1.13e-06	1.3e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—AKT1—breast cancer	1.09e-06	1.25e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—AKT1—breast cancer	9.26e-07	1.06e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PIK3CA—breast cancer	8.75e-07	1e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—AKT1—breast cancer	7.15e-07	8.17e-06	CbGpPWpGaD
